Fig. 4: Trajectory of geometric means for HPV-specific memory B-cells for Cervarix® and Gardasil®9 (per-protocol cohort).
From: Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial
Top panels, HPV16 memory B-cells; bottom panels, HPV18 memory B-cells. Panels for Cervarix®, left; for Gardasil®9, right. a Month 7 log % HPV16-specific memory B-cells against log10 anti-HPV IgG antibody at Month 12 through Month 36. Each participant contributes multiple observations to the scatterplot. b Month 7 log % HPV18-specific memory B-cells against log10 anti-HPV IgG antibody at Month 12 through Month 36. Each participant contributes multiple observations to the scatterplot.
